The present invention relates to a cosmetic composition in the form of an oil-in-water emulsion comprising: (i) at least one C.sub.16-C.sub.30 fatty alcohol; (ii) at least one anionic surfactant of general formula (I): RCOY(CH.sub.2)nSO.sub.3M; (iii) at least one oil; (iv) at least one wax, and (v) at least one hydrophilic solvent, the weight ratio of anionic surfactant(s) of general formula (I)/fatty alcohol(s) ranging from 1/5 to 1/3, said composition comprising from 1% to 10% by weight of wax(es) relative to the total weight of the composition. The present invention also relates to a process for preparing said composition and a cosmetic makeup and/or care process.

To provide a composition in which fine particles of solid lipid such as ceramides are emulsified and dispersed in a stable manner without being crystalized. A dispersion of fine lipid particles containing the following components (A) to (E), wherein the dispersion has a pH of 3.5 or more and 8.0 or less and the fine lipid particles have a heat of fusion of 0.30 J/g or less in a temperature range of 45° C. or more and 80° C. or less and an average particle size of less than 200 nm. (A) one or more selected from the group consisting of a sterol and a derivative thereof, (B) a lipid other than the component (A), the lipid being solid or semi-solid at 25° C., (C) an anionic surfactant, (D) a water-soluble solvent and (E) water.

The present technology includes a set of topical compositions used in treating wounds or scars in accordance with the methods and protocols described herein. The set of topical compositions can include (i) a cleansing composition comprising polydimethylsiloxane (silicone) and Rosmarinus officinalis (rosemary) flower extract; (ii) a first treatment composition comprising Aloe barbadensis (aloe) leaf juice, Macadamia temifolia (macadamia) seed oil, and panthenol (vitamin B5); (iii) a second treatment composition comprising Aloe barbadensis (aloe) leaf extract, sodium hyaluronate, and allantoin; (iv) a third treatment composition comprising snail mucin extract; (v) a fourth treatment composition comprising tocopherol; and (v) a fifth treatment composition comprising retinol.

The present invention relates to pre-formulations comprising low viscosity, non-liquid crystalline, mixtures of: a) at least one neutral diacyl lipid and/or at least one tocopherol; b) at least one phospholipid; c) at least one biocompatible, oxygen containing, low viscosity organic solvent;
wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The preformulations are suitable for generating parenteral, non-parenteral and topical depot compositions for sustained release of active agents. The invention additionally relates to a method of delivery of an active agent comprising administration of a preformulation of the invention, a method of treatment comprising administration of a preformulation of the invention and the use of a preformulation of the invention in a method for the manufacture of a medicament.

A method for producing a powder solid composition including a base containing non-volatile liquid oil, the method includes: blending wax in a powder form into the base; dispersing the base in a solvent; volatilizing the solvent at a first temperature where the wax does not dissolve; and heating the base at a second temperature where the wax dissolves, wherein a blending amount of the non-volatile liquid oil is 15% by mass or more and 40% by mass or less with respect to the base.

A method for producing a powder solid composition including a base containing non-volatile liquid oil, the method includes: blending wax in a powder form into the base; dispersing the base in a solvent; volatilizing the solvent at a first temperature where the wax does not dissolve; and heating the base at a second temperature where the wax dissolves, wherein a blending amount of the non-volatile liquid oil is 15% by mass or more and 40% by mass or less with respect to the base.

The present specification discloses compositions comprising one or more encapsulates comprising one or more agents and methods and uses for the disclosed agents. A composition disclosed herein can be incorporated into a body wash, an after shower body lotion, a shampoo, a conditioner, a soap, a gel, a hand sanitizer, a cream, a spray, a mouse, a lotion, an ointment, a make-up product, a lip balm, a hair spray product, an arachnid/insect repellent or a medicinal product.

The presently disclosed subject matter relates to a system for customizing a cosmetic product. The system includes: an interface device, in electronic communication with a single batch formulation device. The single batch formulation device is configured to formulate a customized cosmetic product, and a threaded container configured to be imported into the single batch formulation device containing a base and exported from the single batch formulation device containing the customized cosmetic.

The present invention relates to a composition in the form of a water-in-oil (W/O) emulsion comprising an oily phase and an aqueous phase, comprising: (a) at least one oil; (b) at least one organic lipophilic gelling agent; (c) at least one pigment coated with isopropyl titanium triisostearate; and (d) water; wherein the amount of the (b) lipophilic gelling agent is greater than 0% by weight and less than 5% by weight relative to the total weight of the composition, and the amount of the aqueous phase is at least 50% by weight relative to the total weight of the composition.

The present invention relates to a composition in the form of a water-in-oil (W/O) emulsion comprising an oily phase and an aqueous phase, comprising: (a) at least one oil; (b) at least one organic lipophilic gelling agent; (c) at least one pigment coated with isopropyl titanium triisostearate; and (d) water; wherein the amount of the (b) lipophilic gelling agent is greater than 0% by weight and less than 5% by weight relative to the total weight of the composition, and the amount of the aqueous phase is at least 50% by weight relative to the total weight of the composition.